The research-peptide market has essentially no regulatory oversight, so quality verification falls on the buyer. This guide lays out the mechanics: batch-specific certificates of analysis showing HPLC purity above 98% and mass-spec confirmation, third-party lab testing, cold-chain shipping, and red flags from missing COAs to implausibly low prices. It is practical guidance, not proof a product is safe or effective. Most of these peptides are unapproved for human use and several are WADA-banned.
Summary drafted from this entry’s sources; editorial review pending.
01Key questions
How is peptide purity verified?
Only through documentation: a batch-specific certificate of analysis showing HPLC purity above 98% with a single peak, mass spectrometry matching the expected molecular weight within 1 Da, and a recent test date. Independent third-party testing runs roughly $200-500 per sample.
What marks an unreliable peptide vendor?
Missing batch-specific certificates of analysis, medical claims, implausibly low prices, no batch numbers or lot tracking, 'proprietary blends', social-media-only sellers, and 'research grade' used as a quality guarantee.
Are research peptides legal in the US?
Most are not FDA-approved and are sold for research use only; FDA warned about BPC-157 in 2023. Approved peptide drugs such as semaglutide and tirzepatide are prescription-only. BPC-157, TB-500, GHRPs and ipamorelin are on the WADA Prohibited List.
How stable are peptides?
Lyophilized peptides stay stable for 24 to 36 months refrigerated and longer frozen, but degrade quickly at room temperature. Once reconstituted they are single-use.
Purpose: Comprehensive guide to sourcing therapeutic peptides — evaluating suppliers, understanding quality control, verifying authenticity, and avoiding compromised or counterfeit products.
02The Quality Problem
Unlike FDA-approved pharmaceuticals, the therapeutic peptide market lacks robust regulatory oversight. This creates significant risks for consumers:
- Variable purity — Peptides may contain impurities, incorrect sequences, or degradation products
- Contamination — Bacterial endotoxins, heavy metals, residual solvents
- Mislabeling — Actual content may not match label claims
- Stability issues — Improper storage/handling degrades potency
Critical: "Peptide grade" and "research grade" are marketing terms — they do NOT guarantee quality, safety, or efficacy.
03Understanding Quality Terminology
Purity Levels
| Grade | Description | Typical Purity | Suitability |
|---|---|---|---|
| Crude | Initial synthesis product | 70-85% | Not suitable for use |
| Research Grade | Basic purification | 90-95% | Laboratory research only |
| Therapeutic Grade | High-purity purification | >98% | Intended for therapeutic use |
| cGMP Grade | FDA-compliant manufacturing | >99% | Pharmaceutical production |
Swipe table →
Note: "Research grade" does NOT mean safe for human use — it means intended for laboratory research.
Certificate of Analysis (COA)
A COA documents the quality parameters for a specific batch. Essential elements:
| Parameter | What It Shows | Acceptable Range |
|---|---|---|
| HPLC Purity | % of correct peptide sequence | >98% |
| Mass Spectrometry | Molecular weight verification | Within 1 Da of expected |
| Appearance | Visual characteristics | White/off-white powder |
| Moisture Content | Water content (lyophilized) | <5% |
| Residual Solvents | Processing chemicals | <100 ppm each |
| Bacterial Endotoxins | Pyrogen contamination | <0.5 EU/mL |
| Sterility | Microbial absence | No growth |
Swipe table →
Red Flag: Suppliers who refuse to provide batch-specific COAs.
04Evaluating Suppliers
Green Flags (Trust Indicators)
✅ Must have: - Batch-specific COAs available - Third-party laboratory testing - GMP-certified or ISO-compliant facilities - Batch numbers traceable to manufacturing records - Professional communication (scientific terminology) - Cold-chain shipping capabilities
✅ Should have: - Responsive customer service - Clear "Research Use Only" disclaimers - Certificate of registration - Independent lab verification (beyond in-house testing) - Transparent about manufacturing location
Red Flags (Warning Signs)
⚠️ Never buy from suppliers who: - Refuse to provide COAs - Advertise as "human use" or "pharmaceutical grade" without FDA approval - Prices too low to be plausible - No batch numbers or lot tracking - Make medical claims (e.g., "cures cancer") - Operate only through social media without a website - Lack proper business registration
⚠️ Warning signs: - "Proprietary blend" without disclosed ingredients - Unrealistic purity claims (>99.9%) - No contact information besides email - Pressure tactics ("only available today!") - Testimonials rather than certificates
Common Scams
| Scam Type | Description | How to Detect |
|---|---|---|
| Underdosed vials | Less peptide than claimed | Check weight; request COA |
| Wrong sequence | Different peptide entirely | Mass spec verification |
| RCAT (Research Chemical Analogue) | Closely related but different compound | Third-party testing |
| ** degradation** | Improper storage leading to breakdown | Appearance; solubility issues |
| Counterfeit packaging | Reused branded vials | Batch verification |
Swipe table →
05Verification Process
Step 1: Request Documentation
Contact the supplier and request:
- Batch number for the product
- Certificate of Analysis (COA) for that batch
- Manufacturing date
- Storage conditions
Legitimate suppliers provide these freely.
Step 2: Verify the COA
Check: - HPLC chromatogram (should show single peak) - Mass spec matches expected molecular weight - Purity >98% - Testing date recent (within 6 months)
Step 3: Third-Party Testing
For high-value or critical applications, consider independent testing:
| Lab | Services | Website |
|---|---|---|
| ** ACS Laboratory** | Purity, contaminants | acslabtest.com |
| Eurofins Lancaster Laboratories | Full testing | eurofins.com |
| APItek | Peptide analysis | apitek.com |
Swipe table →
Cost: ~$200-500 per sample depending on tests
Step 4: Physical Inspection
Upon receipt, verify:
| Check | What to Look For |
|---|---|
| Packaging | Glass vial, intact seal, no damage |
| Appearance | White/fluffy powder; no clumping, discoloration |
| Smell | No unusual odor (should be odorless) |
Swipe table →
06Sourcing by Peptide Type
FDA-Approved Peptides (Pharmaceutical)
| Peptide | Brand Names | Source |
|---|---|---|
| Semaglutide | Ozempic®, Wegovy® | Pharmacy with prescription |
| Tirzepatide | Mounjaro®, Zepbound® | Pharmacy with prescription |
| Teriparatide | Forteo® | Pharmacy with prescription |
| Tesamorelin | Vioris® | Pharmacy with prescription |
Swipe table →
Note: These require prescriptions and should be obtained through legitimate pharmacies.
Non-FDA-Approved Peptides (Research Use)
⚠️ Warning: These are not approved for human use. Use only under professional supervision.
| Peptide | Common Sources | Quality Concern |
|---|---|---|
| BPC-157 | Many suppliers | Variable; quality critical |
| TB-500 | Many suppliers | Often underdosed |
| Thymosin Alpha-1 | Limited suppliers | Manufacturing complexity |
| GH Secretagogues | Many suppliers | Purity issues |
Swipe table →
07Regulatory Status
United States
| Status | Peptides | Regulation |
|---|---|---|
| FDA Approved | GLP-1 agonists, some others | Prescription only |
| Not Approved | BPC-157, TB-500, most others | "Research use only" |
| Status Unclear | Various | Case-by-case |
Swipe table →
FDA Warning (2023): The FDA has issued warnings about BPC-157, noting lack of safety data and adverse event reports.
International
| Country | Status | Notes |
|---|---|---|
| Russia | Some approved | Khavinson peptides, Thymalin |
| Italy | Some approved | Thymosin alpha-1 (Zadaxin) |
| China | Varies | Manufacturing hub |
| Japan | Varies | Stringent regulation |
Swipe table →
WADA Status
Several peptides are banned by WADA (World Anti-Doping Agency):
- BPC-157 (as of 2023)
- TB-500
- GHRPs (growth hormone-releasing peptides)
- Ipamorelin
Athletes: Check WADA Prohibited List before use.
08Connections
09Sources
10Entry history
Latest content update.
Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.